What is Pocket Pills?
Founded in 2018 and headquartered in Surrey, British Columbia, Pocket Pills operates as a sophisticated online pharmacy platform. The company leverages mobile technology to streamline the prescription fulfillment process, offering a seamless user experience for Canadians. By digitizing the pharmacy experience, Pocket Pills addresses critical inefficiencies in medication management, positioning itself as a key player in the burgeoning digital health sector. The company's business model focuses on convenience, accessibility, and patient-centric care, effectively bridging the gap between traditional clinical services and modern digital convenience.
How much funding has Pocket Pills raised?
Pocket Pills has raised a total of $37.4M across 2 funding rounds:
Series A
$7.3M
Series B
$30M
Series A (2020): $7.4M with participation from Waterbridge
Series B (2021): $30M led by WaterBridge Ventures and TELUS Ventures
Key Investors in Pocket Pills
WaterBridge Ventures
A venture capital firm dedicated to helping entrepreneurs build generational companies across various sectors, with a specific focus on backing contrarian founders.
TELUS Ventures
The strategic investment arm of TELUS Corporation, providing capital and resources to innovative companies within the telecommunications and information technology sectors.
Waterbridge
An early-stage investment partner that participated in the initial funding rounds to support the company's foundational growth.
What's next for Pocket Pills?
With the recent influx of capital, Pocket Pills is expected to prioritize the scaling of its logistics infrastructure and the expansion of its digital service offerings. The company is likely to focus on enhancing its technological stack to support a larger user base while maintaining the high standards of pharmaceutical compliance required in the Canadian market. Strategic partnerships with telecommunications and healthcare providers will likely remain a core component of their growth strategy, enabling the firm to leverage existing networks to reach a broader demographic. As the company moves beyond its Series B phase, the focus will shift toward long-term sustainability and market dominance in the digital pharmacy space, potentially exploring new therapeutic areas or integrated health management solutions.
See full Pocket Pills company page
